Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Visentin

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
The Journal of Biological Chemistry|December 18, 2020
Cholesterol stimulates the cellular uptake of L-carnitine by the carnitine/organic cation transporter novel 2 (OCTN2)Lu Zhang, Ting Gui, Lara Console, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 26, 2018
Fluorocholine Transport Mediated by the Organic Cation Transporter 2 (OCT2, SLC22A2): Implication for Imaging of Kidney TumorsMichele Visentin, Angelo Torozi, Zhibo Gai, et al.
International Journal of Molecular Sciences|February 11, 2023
Plasma Sphingoid Base Profiles of Patients Diagnosed with Intrinsic or Idiosyncratic Drug-induced Liver InjuryZhibo Gai, Sophia L Samodelov, Irina Alecu, et al.
Scientific Reports|July 16, 2024
L-carnitine co-administration prevents colistin-induced mitochondrial permeability transition and reduces the risk of acute kidney injury in miceSophia L Samodelov, Zhibo Gai, Francesca De Luca, et al.
Frontiers in Medicine|January 21, 2022
The Role of NF-kB in the Downregulation of Organic Cation Transporter 2 Expression and Renal Cation Secretion in Kidney DiseaseChao Han, Juan Zheng, Fengyi Wang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 5, 2023
Association Between Gadoxetic Acid-Enhanced Magnetic Resonance Imaging, Organic Anion Transporters, and Farnesoid X Receptor in Benign Focal Liver LesionsBelle V van Rosmalen, Michele Visentin, Alicia Furumaya, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 29, 2019
Farnesoid X receptor activation induces the degradation of hepatotoxic 1-deoxysphingolipids in non-alcoholic fatty liver diseaseZhibo Gai, Ting Gui, Irina Alecu, et al.
Biochemical Pharmacology|May 31, 2022
Corrigendum to "The role of cholesterol recognition (CARC/CRAC) mirror codes in the allosterism of the human organic cation transporter 2 (OCT2, SLC22A2)" [Biochem. Pharmacol. 194 (2021) 114840]Morena L Sutter, Lara Console, Anne-Fleur Fahner, et al.
Molecular Pharmacology|May 11, 2018
Effects of Farnesoid X Receptor Activation on Arachidonic Acid Metabolism, NF-kB Signaling, and Hepatic InflammationZhibo Gai, Michele Visentin, Ting Gui, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 14, 2019
microRNA-206 modulates the hepatic expression of the organic anion-transporting polypeptide 1B1Tämer El Saadany, Belle van Rosmalen, Zhibo Gai, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|December 18, 2020
Cholesterol stimulates the cellular uptake of L-carnitine by the carnitine/organic cation transporter novel 2 (OCTN2)Lu Zhang, Ting Gui, Lara Console, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 26, 2018
Fluorocholine Transport Mediated by the Organic Cation Transporter 2 (OCT2, SLC22A2): Implication for Imaging of Kidney TumorsMichele Visentin, Angelo Torozi, Zhibo Gai, et al.
International Journal of Molecular Sciences|February 11, 2023
Plasma Sphingoid Base Profiles of Patients Diagnosed with Intrinsic or Idiosyncratic Drug-induced Liver InjuryZhibo Gai, Sophia L Samodelov, Irina Alecu, et al.
Scientific Reports|July 16, 2024
L-carnitine co-administration prevents colistin-induced mitochondrial permeability transition and reduces the risk of acute kidney injury in miceSophia L Samodelov, Zhibo Gai, Francesca De Luca, et al.
Frontiers in Medicine|January 21, 2022
The Role of NF-kB in the Downregulation of Organic Cation Transporter 2 Expression and Renal Cation Secretion in Kidney DiseaseChao Han, Juan Zheng, Fengyi Wang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 5, 2023
Association Between Gadoxetic Acid-Enhanced Magnetic Resonance Imaging, Organic Anion Transporters, and Farnesoid X Receptor in Benign Focal Liver LesionsBelle V van Rosmalen, Michele Visentin, Alicia Furumaya, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 29, 2019
Farnesoid X receptor activation induces the degradation of hepatotoxic 1-deoxysphingolipids in non-alcoholic fatty liver diseaseZhibo Gai, Ting Gui, Irina Alecu, et al.
Biochemical Pharmacology|May 31, 2022
Corrigendum to "The role of cholesterol recognition (CARC/CRAC) mirror codes in the allosterism of the human organic cation transporter 2 (OCT2, SLC22A2)" [Biochem. Pharmacol. 194 (2021) 114840]Morena L Sutter, Lara Console, Anne-Fleur Fahner, et al.
Molecular Pharmacology|May 11, 2018
Effects of Farnesoid X Receptor Activation on Arachidonic Acid Metabolism, NF-kB Signaling, and Hepatic InflammationZhibo Gai, Michele Visentin, Ting Gui, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 14, 2019
microRNA-206 modulates the hepatic expression of the organic anion-transporting polypeptide 1B1Tämer El Saadany, Belle van Rosmalen, Zhibo Gai, et al.
Pageof 6